Notably, in Goto-Kakizaki (GK) rats—a model of type 2 diabetes—pharmacological enhancement of O-GlcNAcylation in pancreatic islets leads to impaired GSIS, highlighting the critical role of O-GlcNAcylation in the regulation of insulin secretion [171]. This evidence concerns the gene INS and type 2 diabetes mellitus.